Investing Ideas
/
Norwegian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Norwegian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Vistin Pharma

Market Cap: NOK 1.0b

Through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide.

VISTN

NOK 23.00

-5.7%

-3.8%